Added Value of an Anti-Ebola Serology for the Management of Clinically Suspected Ebola Virus Disease Patients Discharged as Negative in an Epidemic Context.

Antoine Nkuba-NdayeDaniel Mukadi-BamulekaJunior Bulabula-PengeGuillaume ThaurignacFrançois Edidi-AtaniFabrice Mambu-MbikaBernice Danga-YemaMeris Matondo-KuamfumuEddy Kinganda-LusamakiNella BisentoRaphaël Lumembe-NumbiGabriel Kabamba-LungenyiDivine Kitsa-MutsumbirwaNelson Kambale-SivihwaFrançois BoillotEric DelaportePlacide Mbala-KingebeniAhidjo Ayouba Martine PeetersSteve Ahuka-Mundeke

Published in: The Journal of infectious diseases (2022)

These findings emphasize the usefulness of an EBOV serology analysis and the importance of extending epidemic surveillance to clinically suspected cases who were discharged as negative.

Keyphrases

end stage renal disease
pulmonary embolism
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
patient reported